Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Solstice NeuroSciences
Solstice NeuroSciences
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Myobloc
Rimabotulinumtoxinb
2000-12-08
Neck pain
,
Torticollis
,
Dystonia
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Rimabotulinumtoxinb
stroke
,
neoplasms
,
wounds and injuries
,
spinal cord injuries
,
brain injuries
,
muscle spasticity
,
muscular atrophy
,
dystonic disorders
,
dystonia
Bevifimod
primary ovarian insufficiency
,
female infertility
,
ovulation induction
,
infertility
,
asthma
,
fertilization in vitro
,
dysmenorrhea
,
contraception
,
proteinuria
,
cardiovascular diseases
,
myocardial infarction
,
ischemia
,
acute coronary syndrome
,
myocardial ischemia
,
angina pectoris
,
psoriasis
,
ovarian hyperstimulation syndrome
,
pregnancy
,
congenital abnormalities
,
hemorrhage
,
hypercholesterolemia
,
dyslipidemias
Azzalure
muscle spasticity
,
stroke
,
atrial fibrillation
,
abdominal hernia
,
ventral hernia
,
neuralgia
,
interstitial cystitis
,
migraine disorders
,
seizures
,
facies
,
cerebral palsy
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use